Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis

Siliang Wang(China Medical University), Yin Lu(Nanjing University of Chinese Medicine)

Oncotarget

January 16, 2017

10.18632/oncotarget.14675

Cited by 71

Related Papers

Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways

|PLoS ONE|2015|103

Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review)

|International Journal of Oncology|2020|67

MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2

|Oncology Reports|2014|64

Xanthatin Induces Cell Cycle Arrest at G2/M Checkpoint and Apoptosis via Disrupting NF-κB Pathway in A549 Non-Small-Cell Lung Cancer Cells

|Molecules|2012|60

Paeonol inhibits <scp>B</scp>16<scp>F</scp>10 melanoma metastasis <i>In vitro</i> and <i>In Vivo</i> via disrupting proinflammatory cytokines‐mediated <scp>NF</scp>‐κ<scp>B</scp> and <scp>STAT</scp>3 pathways

|IUBMB Life|2015|59